UBS Backs Rithm Capital with Buy Rating, Sees Strategic Growth in $16 Billion Acquisition Spree
UBS initiates coverage on Rithm Capital with a Buy rating and a $16 price target, highlighting the REIT's aggressive acquisition strategy—including the purchases of Paramount Group and Crestline—as a key driver for expanding its asset management footprint and unlocking shareholder value.